CAS 825658-06-8

ML335

CAS : 825658-06-8

Formule : C₁₅H₁₄Cl₂N₂O₃S

Degré de pureté : 98%

Masse moléculaire : 373.2543

Ref: IN-DA01EOI8

ML335

CAS : 825658-06-8

ML335

Degré de pureté : ≥98%

Masse moléculaire : 373.25g/mol

Ref: 54-BUP11593

ML335

CAS : 825658-06-8

ML335 is a selective activator of TREK-1 and TREK-2.

Formule : C₁₅H₁₄Cl₂N₂O₃S

Degré de pureté : 99.73% - 99.79%

Couleur et forme : Solid

Masse moléculaire : 373.25

Ref: TM-T4224

ML335

CAS : 825658-06-8

ML335 is a selective inhibitor of the enzyme fatty acid amide hydrolase (FAAH), which is responsible for the degradation of endogenous cannabinoids. ML335 has been shown to inhibit FAAH with an IC50 value of 0.2 μM, and thereby increase the levels of endocannabinoids in mice and rats. This compound also binds to other basic proteins, including voltage-gated potassium channels, and may have analgesic effects as a result. The activation of these channels leads to increased neuronal excitability and pain relief. It is thought that ML335 could be used for chronic pain treatment due to its ability to inhibit FAAH and its downstream effects on other proteins.

Formule : C₁₅H₁₄Cl₂N₂O₃S

Degré de pureté : Min. 95%

Masse moléculaire : 373.25 g/mol

Ref: 3D-AIB65806